AnalystsPaul MatteisPaul Matteis's Stock Forecasts
AnalystsPaul Matteis
Analyst Ranking
Bottom 11%
#3940 out of 4414 analysts
Average Return
-7.45%
Win Rate
35%16 out of 46
Risk vs Reward
Poor
Good
Paul Matteis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gw Pharmaceuticals PLCGWPH | +64.79% | $98.51 | $162.33 | 2017-10-01 - 2018-10-02 | Buy |
Neurocrine Biosciences IncNBIX | +59.15% | $72.78 | $115.83 | 2017-11-01 - 2018-11-02 | Buy |
Avadel Pharmaceuticals PLCAVDL | +53.86% | $6.35 | $9.77 | 2020-03-11 - 2021-03-12 | Strong Buy |
Prevail Therapeutics IncPRVL | +51.12% | $15.22 | $23.00 | 2020-07-15 - 2021-01-21 | Strong Buy |
Pepgen IncPEPG | +41.02% | $11.19 | $15.78 | 2022-05-30 - 2023-05-30 | Strong Buy |
Paul Matteis Analyst Color
Get additional color on Paul Matteis's coverage of popular stocks
Paul Matteis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $20.00 | +67.50% | Initiates Coverage On | a day ago |
Vertex Pharmaceuticals IncVRTX | 12 | Hold | $373.00 | +7.48% | Reiterates | 7 days ago |
Vistagen Therapeutics IncVTGN | 1 | Strong Buy | $12.00 | +222.58% | Initiates Coverage On | 15 days ago |
Neumora Therapeutics IncNMRA | 1 | Strong Buy | $26.00 | +115.23% | Initiates Coverage On | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 6 | Strong Buy | $240.00 | +48.74% | Reiterates | 2 months ago |
Alector IncALEC | 3 | Hold | $8.00 | +55.04% | Maintains | 4 months ago |
Sage Therapeutics IncSAGE | 3 | Hold | $22.00 | +14.17% | Downgrades | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $108.00 | +23.06% | Maintains | 4 months ago |
Biogen IncBIIB | 5 | Strong Buy | $320.00 | +40.72% | Maintains | 4 months ago |
Pepgen IncPEPG | 2 | Strong Buy | $24.00 | +427.47% | Reiterates | 5 months ago |
Alkermes PLCALKS | 4 | Hold | $33.00 | +40.13% | Maintains | 6 months ago |
Neurocrine Biosciences IncNBIX | 4 | Strong Buy | $125.00 | +10.78% | Maintains | 6 months ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $295.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Strong Buy | $54.00 | N/A | Maintains | a year ago |
Athira Pharma IncATHA | 2 | Hold | $5.00 | N/A | Downgrades | a year ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $32.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Eliem Therapeutics IncELYM | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
Gh Research PLCGHRS | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Acadia Pharmaceuticals IncACAD | 3 | Hold | $27.00 | N/A | Downgrades | 3 years ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 3 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Gw Pharmaceuticals PLCGWPH | 4 | Hold | $140.00 | N/A | Downgrades | 3 years ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Denali Therapeutics IncDNLI | 1 | Hold | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Zogenix IncZGNX | 3 | Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Acorda Therapeutics IncACOR | 1 | Hold | $2,280.00 | N/A | Maintains | 5 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | $48.00 | N/A | Maintains | 5 years ago |
Akcea Therapeutics IncAKCA | 2 | Hold | $31.00 | N/A | Maintains | 5 years ago |
Obseva SaOBSVF | 1 | Buy | $18.00 | N/A | Maintains | 6 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $64.00 | N/A | Maintains | 6 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.